SRNE OTC
Sorrento Therapeutics, Inc.
1W: +0.0%
1M: +33.3%
3M: +14.3%
YTD: -74.6%
1Y: -77.1%
3Y: -96.1%
5Y: -99.3%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±52.7%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$64M
Revenue
+16.9% YoY
$-549M
Net Income
-4.7% YoY
$-243M
Free Cash Flow
+25.9% YoY
43.7%
Gross Margin
-514.0%
Op. Margin
-633.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE1502.8%
ROA-100.9%
ROIC468.4%
Valuation
P/E-0.0
P/B-0.0
EV/EBITDA-0.2
Leverage
Debt/Equity-1.01
Current Ratio0.50
Interest Cov.-80.2x
Quality Scores
Piotroski F2/9
Altman Z-10.88
Beneish M-5.43